Pacira BioSciences PCRX
NASDAQ PCRX
$25.05 -0.60 (-2.34%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Finished Goods (2011 - 2014)

Updated

Pacira BioSciences' Finished Goods came in at $6.36 million for Q2 2014, up 49.0% from $4.27 million a year earlier.

Analysis

Pacira BioSciences (PCRX) Finished Goods (2011 - 2014) Analysis & Trends

At the end of FY2013, Pacira BioSciences' Finished Goods was $3.95 million, up 95.6% from FY2012.

  • Going back by year, Finished Goods was $2.02 million in FY2012 (+602.8%) and $287,000 in FY2011.
  • The Q2 2014 figure represents the highest quarterly Finished Goods since Q3 2012.
  • Year-over-year, Finished Goods increased in three of the last four quarters, with growth averaging 185.4%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Pacira BioSciences 1.02 Bn 83.47 Mn 148.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 6.36 Mn
Dec 31, 2013 3.95 Mn
Jun 30, 2013 4.27 Mn
Mar 31, 2013 3.79 Mn
Dec 31, 2012 2.02 Mn
Sep 30, 2012 6.39 Mn
Jun 30, 2012 4.53 Mn
Dec 31, 2011 287,000.00
API Access

Pacira BioSciences Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=PCRX&period=max&api_key=YOUR_API_KEY